{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:16:52Z","timestamp":1777591012235,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Government-funded Clinical Medicine Outstanding Talent Training Project","award":["ZF2025150"],"award-info":[{"award-number":["ZF2025150"]}]},{"name":"Government-funded Clinical Medicine Outstanding Talent Training Project","award":["ZF2025150"],"award-info":[{"award-number":["ZF2025150"]}]},{"name":"Government-funded Clinical Medicine Outstanding Talent Training Project","award":["ZF2025150"],"award-info":[{"award-number":["ZF2025150"]}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2020206478"],"award-info":[{"award-number":["H2020206478"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2020206478"],"award-info":[{"award-number":["H2020206478"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"crossref","award":["H2020206478"],"award-info":[{"award-number":["H2020206478"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Central Government Guides Local Science and Technology Development Project","award":["246Z7711G"],"award-info":[{"award-number":["246Z7711G"]}]},{"name":"Central Government Guides Local Science and Technology Development Project","award":["246Z7711G"],"award-info":[{"award-number":["246Z7711G"]}]},{"name":"Central Government Guides Local Science and Technology Development Project","award":["246Z7711G"],"award-info":[{"award-number":["246Z7711G"]}]},{"name":"Projects of Medical Science Research of the Health Commission of Hebei Province, China","award":["20210725, 20210513, 20210372 and 20170642"],"award-info":[{"award-number":["20210725, 20210513, 20210372 and 20170642"]}]},{"name":"Projects of Medical Science Research of the Health Commission of Hebei Province, China","award":["20210725, 20210513, 20210372 and 20170642"],"award-info":[{"award-number":["20210725, 20210513, 20210372 and 20170642"]}]},{"name":"Projects of Medical Science Research of the Health Commission of Hebei Province, China","award":["20210725, 20210513, 20210372 and 20170642"],"award-info":[{"award-number":["20210725, 20210513, 20210372 and 20170642"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Coronary heart disease (CHD) is a severe diabetic vascular complication and the main cause of mortality among diabetes patients. Early diagnosis of CHD could prevent its development. Both omentin-1 (Oment-1) and the long noncoding RNA MALAT1 (lncRNA MALAT1) can be detected in peripheral blood and exhibit protective or detrimental effects on CHD. However, whether these two factors could be predictive of CHD in T2DM patients remains unclear. Therefore, this study aimed to investigate the associations of circulating Oment-1 levels and the expression of MALAT1 with CHD in T2DM patients and to assess their predictive efficacy. A total of 137 T2DM patients were enrolled, including 68 patients without CHD (T2DM group) and 69 patients with CHD (T2DM\u2009+\u2009CHD group). Clinical parameters were collected, and plasma Oment-1 was measured by enzyme-linked immunosorbent assay (ELISA). RNA was isolated from peripheral monocytes, and the expression of MALAT1 was determined by quantitative PCR. Cardiac function was measured by echocardiography. Compared with that in T2DM patients, the plasma Oment-1 level was significantly lower, while the expression of MALAT1 was significantly greater in T2DM\u2009+\u2009CHD patients (all P values\u2009&lt;\u20090.01). Bivariate correlation analysis indicated that Oment-1 was positively correlated with the left ventricular ejection fraction (LVEF) (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.01). MALAT1 expression was negatively correlated with LVEF but positively correlated with age and DM duration (\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.05). Binary logistic regression suggested that Oment-1 and MALAT1 were significantly associated with the presence of CHD. Receiver operating characteristic (ROC) curve analysis demonstrated that both Oment-1 (AUC\u2009=\u20090.663, sensitivity\u2009=\u200975%, specificity\u2009=\u200949%) and MALAT1 (AUC\u2009=\u20090.749, sensitivity\u2009=\u200973%, specificity\u2009=\u200966%) had significant diagnostic value for CHD among T2DM patients. Notably, the combination of Oment-1 and MALAT1 exhibited better diagnostic efficiency (AUC\u2009=\u20090.771, sensitivity\u2009=\u200966.7%, specificity\u2009=\u200975.3%). In conclusion, decreased circulating Oment-1 levels and increased MALAT1 expression are closely associated with CHD in T2DM patients, and their combination offers superior diagnostic efficiency, suggesting Oment-1 and MALAT1 may serve as a non-invasive tool for the early CHD detection and risk stratification in high-risk T2DM patients. Further studies are warranted to explore the pathophysiological mechanisms of Omentin-1 and MALAT1 in the pathogenesis of CHD in T2DM and to validate their clinical utility as potential biomarkers in large cohort studies.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-01153-5","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T06:29:49Z","timestamp":1746944989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Associations of circulating omentin-1 levels and long noncoding RNA MALAT1 expression with coronary heart disease in patients with type 2 diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"given":"Meimei","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinchao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Lou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"1153_CR1","doi-asserted-by":"publisher","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun, H. et al. Diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 183, 109119 (2022).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"1","key":"1153_CR2","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12933-018-0703-2","volume":"17","author":"WD Strain","year":"2018","unstructured":"Strain, W. D. & Pald\u00e1nius, P. M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc. Diabetol. 17 (1), 57 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"1153_CR3","first-page":"e17347","volume":"13","author":"P Bai","year":"2021","unstructured":"Bai, P. et al. Association between coronary artery disease and plasma Omentin-1 levels. Cureus 13 (8), e17347 (2021).","journal-title":"Cureus"},{"issue":"1","key":"1153_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12933-019-0880-7","volume":"18","author":"F Biscetti","year":"2019","unstructured":"Biscetti, F. et al. Association between plasma omentin-1 levels in type 2 diabetic patients and peripheral artery disease. Cardiovasc. Diabetol. 18 (1), 74 (2019).","journal-title":"Cardiovasc. Diabetol."},{"key":"1153_CR5","doi-asserted-by":"crossref","unstructured":"Eimal Latif, A. H. et al. Association of plasma Omentin-1 levels with diabetes and its complications. Cureus, 13(9): p. e18203. (2021).","DOI":"10.7759\/cureus.18203"},{"key":"1153_CR6","doi-asserted-by":"crossref","unstructured":"Binti Kamaruddin, N. A. et al. Cytoprotective role of omentin against oxidative Stress-Induced vascular endothelial cells injury. Molecules, 25(11), 2534 (2020).","DOI":"10.3390\/molecules25112534"},{"issue":"3","key":"1153_CR7","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1080\/14728222.2022.2037556","volume":"26","author":"A Zhao","year":"2022","unstructured":"Zhao, A. et al. Omentin-1: a newly discovered warrior against metabolic related diseases. Expert Opin. Ther. Targets. 26 (3), 275\u2013289 (2022).","journal-title":"Expert Opin. Ther. Targets"},{"key":"1153_CR8","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12933-016-0406-5","volume":"15","author":"Y Du","year":"2016","unstructured":"Du, Y. et al. Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis. Cardiovasc. Diabetol. 15, 90 (2016).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"1153_CR9","doi-asserted-by":"publisher","first-page":"9636","DOI":"10.1038\/s41598-020-66816-x","volume":"10","author":"F Genre","year":"2020","unstructured":"Genre, F. et al. Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis. Sci. Rep. 10 (1), 9636 (2020).","journal-title":"Sci. Rep."},{"key":"1153_CR10","doi-asserted-by":"crossref","unstructured":"Christodoulatos, G. S. et al. Circulating Omentin-1 as a biomarker at the intersection of postmenopausal breast Cancer occurrence and cardiometabolic risk: an observational Cross-Sectional study. Biomolecules, 11(11), 1609 (2021).","DOI":"10.3390\/biom11111609"},{"issue":"2","key":"1153_CR11","doi-asserted-by":"publisher","first-page":"353","DOI":"10.14336\/AD.2018.0617","volume":"10","author":"Y Zhang","year":"2019","unstructured":"Zhang, Y. et al. MicroRNAs or long noncoding RNAs in diagnosis and prognosis of coronary artery disease. Aging Dis. 10 (2), 353\u2013366 (2019).","journal-title":"Aging Dis."},{"issue":"3","key":"1153_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/iub.2210","volume":"72","author":"Y Yan","year":"2020","unstructured":"Yan, Y., Song, D., Song, X. & Song, C. The role of LncRNA MALAT1 in cardiovascular disease. IUBMB Life. 72 (3), 334\u2013342 (2020).","journal-title":"IUBMB Life"},{"key":"1153_CR13","doi-asserted-by":"publisher","first-page":"106841","DOI":"10.1016\/j.vph.2021.106841","volume":"138","author":"C Zhao","year":"2021","unstructured":"Zhao, C. et al. The LncRNA MALAT1 participates in regulating coronary slow flow endothelial dysfunction through the miR-181b-5p-MEF2A-ET-1 axis. Vascul Pharmacol. 138, 106841 (2021).","journal-title":"Vascul Pharmacol."},{"issue":"6","key":"1153_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3892\/etm.2020.9258","volume":"20","author":"S Qiu","year":"2020","unstructured":"Qiu, S. & Sun, J. lncRNA-MALAT1 expression in patients with coronary atherosclerosis and its predictive value for in-stent restenosis. Exp. Ther. Med. 20 (6), 129 (2020).","journal-title":"Exp. Ther. Med."},{"key":"1153_CR15","doi-asserted-by":"crossref","unstructured":"Barbalata, T., Niculescu, L. S., Stancu, C. S., Pinet, F. & Sima, A. V. Elevated levels of Circulating LncRNAs LIPCAR and MALAT1 predict an unfavorable outcome in acute coronary syndrome patients. Int. J. Mol. Sci. 24(15), 12076 (2023).","DOI":"10.3390\/ijms241512076"},{"key":"1153_CR16","doi-asserted-by":"crossref","unstructured":"Sena, C. M. Omentin: A key player in glucose homeostasis, atheroprotection, and Anti-Inflammatory potential for cardiovascular health in obesity and diabetes. Biomedicines 12(2), 284 (2024).","DOI":"10.3390\/biomedicines12020284"},{"key":"1153_CR17","doi-asserted-by":"publisher","first-page":"155364","DOI":"10.1016\/j.cyto.2020.155364","volume":"138","author":"NPE Kadoglou","year":"2021","unstructured":"Kadoglou, N. P. E., Kassimis, G., Patsourakos, N., Kanonidis, I. & Valsami, G. Omentin-1 and Vaspin serum levels in patients with pre-clinical carotid atherosclerosis and the effect of Statin therapy on them. Cytokine 138, 155364 (2021).","journal-title":"Cytokine"},{"issue":"2","key":"1153_CR18","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/FJC.0000000000001061","volume":"78","author":"Z Shi","year":"2021","unstructured":"Shi, Z., Zheng, Z., Lin, X. & Ma, H. Long noncoding RNA MALAT1 regulates the progression of atherosclerosis by miR-330-5p\/NF-\u03baB signal pathway. J. Cardiovasc. Pharmacol. 78 (2), 235\u2013246 (2021).","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"1153_CR19","first-page":"16","volume":"49","author":"A Grimaldi","year":"1999","unstructured":"Grimaldi, A. & Heurtier, A. [Diagnostic criteria for type 2. diabetes] Rev. Prat. 49 (1), 16\u201321 (1999).","journal-title":"diabetes] Rev. Prat"},{"issue":"3","key":"1153_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti, J. et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur. Heart J. 41 (3), 407\u2013477 (2020).","journal-title":"Eur. Heart J."},{"issue":"4s","key":"1153_CR21","first-page":"S1","volume":"100","author":"Kidney Disease","year":"2021","unstructured":"Kidney Disease. Improving global outcomes (KDIGO) glomerular diseases work group.kdigo 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 100 (4s), S1\u2013s276 (2021).","journal-title":"Kidney Int."},{"issue":"1","key":"1153_CR22","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson, T. R., Acs, A., Ludwig, C. & Panton, U. H. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc. Diabetol. 17 (1), 83 (2018).","journal-title":"Cardiovasc. Diabetol."},{"issue":"1","key":"1153_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.2478\/enr-2023-0029","volume":"57","author":"S Ali","year":"2023","unstructured":"Ali, S. et al. Evaluation of serum adipokines (omentin-1 and visfatin) in coronary artery disease at a North Indian hospital. Endocr. Regul. 57 (1), 262\u2013268 (2023).","journal-title":"Endocr. Regul."},{"issue":"10","key":"1153_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1177\/0003319713511322","volume":"65","author":"I Onur","year":"2014","unstructured":"Onur, I. et al. Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women. Angiology 65 (10), 896\u2013900 (2014).","journal-title":"Angiology"},{"issue":"2","key":"1153_CR25","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.atherosclerosis.2011.08.017","volume":"219","author":"R Shibata","year":"2011","unstructured":"Shibata, R. et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis 219 (2), 811\u2013814 (2011).","journal-title":"Atherosclerosis"},{"key":"1153_CR26","doi-asserted-by":"crossref","unstructured":"Chen, Y. et al. Omentin-1 Ameliorated Free Fatty Acid-Induced Impairment in Proliferation, Migration, and Inflammatory States of HUVECs. Cardiol Res Pract, 2020: p. 3054379. (2020).","DOI":"10.1155\/2020\/3054379"},{"key":"1153_CR27","doi-asserted-by":"publisher","first-page":"114489","DOI":"10.1016\/j.bcp.2021.114489","volume":"186","author":"Q Dong","year":"2021","unstructured":"Dong, Q. et al. Tetrahydroxystilbene glycoside improves endothelial dysfunction and hypertension in obese rats: the role of omentin-1. Biochem. Pharmacol. 186, 114489 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"1153_CR28","doi-asserted-by":"publisher","first-page":"113830","DOI":"10.1016\/j.bcp.2020.113830","volume":"174","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Omentin-1 protects against high glucose-induced endothelial dysfunction via the AMPK\/PPAR\u03b4 signaling pathway. Biochem. Pharmacol. 174, 113830 (2020).","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"1153_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/cvr\/cvv282","volume":"110","author":"M Hiramatsu-Ito","year":"2016","unstructured":"Hiramatsu-Ito, M. et al. Omentin attenuates atherosclerotic lesion formation in Apolipoprotein E-deficient mice. Cardiovasc. Res. 110 (1), 107\u2013117 (2016).","journal-title":"Cardiovasc. Res."},{"key":"1153_CR30","doi-asserted-by":"publisher","first-page":"757926","DOI":"10.3389\/fcvm.2021.757926","volume":"8","author":"X Lin","year":"2021","unstructured":"Lin, X. et al. Omentin-1 modulates macrophage function via integrin receptors \u0391v\u03b23 and \u0391v\u03b25 and reverses plaque vulnerability in animal models of atherosclerosis. Front. Cardiovasc. Med. 8, 757926 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"1153_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/1389201020666190404125213","volume":"20","author":"YL Tan","year":"2019","unstructured":"Tan, Y. L. et al. Tanshinone IIA promotes macrophage cholesterol efflux and attenuates atherosclerosis of apoE-\/- mice by Omentin-1\/ABCA1 pathway. Curr. Pharm. Biotechnol. 20 (5), 422\u2013432 (2019).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"1153_CR32","doi-asserted-by":"publisher","first-page":"p6762825","DOI":"10.1155\/2016\/6762825","volume":"2016","author":"Y Huang","year":"2016","unstructured":"Huang, Y. et al. Circulating Omentin-1 levels are decreased in dilated cardiomyopathy patients with overt heart failure. Dis. Markers. 2016, p6762825 (2016).","journal-title":"Dis. Markers"},{"key":"1153_CR33","doi-asserted-by":"publisher","first-page":"109418","DOI":"10.1016\/j.biopha.2019.109418","volume":"119","author":"F Li","year":"2019","unstructured":"Li, F. et al. YiQiFuMai powder injection ameliorates chronic heart failure through cross-talk between adipose tissue and cardiomyocytes via up-regulation of Circulating adipokine omentin. Biomed. Pharmacother. 119, 109418 (2019).","journal-title":"Biomed. Pharmacother"},{"issue":"2","key":"1153_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1253\/circrep.CR-22-0079","volume":"5","author":"M Ito","year":"2023","unstructured":"Ito, M. et al. Omentin modulates chronic cardiac remodeling after myocardial Infarction. Circ. Rep. 5 (2), 46\u201354 (2023).","journal-title":"Circ. Rep."},{"issue":"1","key":"1153_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12967-022-03642-x","volume":"20","author":"J Hu","year":"2022","unstructured":"Hu, J. et al. Omentin1 ameliorates myocardial ischemia-induced heart failure via SIRT3\/FOXO3a-dependent mitochondrial dynamical homeostasis and mitophagy. J. Transl Med. 20 (1), 447 (2022).","journal-title":"J. Transl Med."},{"issue":"2","key":"1153_CR36","doi-asserted-by":"publisher","first-page":"e0212782","DOI":"10.1371\/journal.pone.0212782","volume":"14","author":"R Lage","year":"2019","unstructured":"Lage, R., Cebro-M\u00e1rquez, M., Rodr\u00edguez-Ma\u00f1ero, M., Gonz\u00e1lez-Juanatey, J. R. & Moscoso, I. Omentin protects H9c2 cells against docetaxel cardiotoxicity. PLoS One. 14 (2), e0212782 (2019).","journal-title":"PLoS One"},{"issue":"5","key":"1153_CR37","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1080\/13813455.2020.1768410","volume":"128","author":"N Sohrabifar","year":"2022","unstructured":"Sohrabifar, N., Ghaderian, S. M. H., Alipour Parsa, S., Ghaedi, H. & Jafari, H. Variation in the expression level of MALAT1, MIAT and XIST LncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus. Arch. Physiol. Biochem. 128 (5), 1308\u20131315 (2022).","journal-title":"Arch. Physiol. Biochem."},{"issue":"4","key":"1153_CR38","doi-asserted-by":"publisher","first-page":"e23593","DOI":"10.1002\/jcla.23593","volume":"35","author":"F Lv","year":"2021","unstructured":"Lv, F., Liu, L., Feng, Q. & Yang, X. Long non-coding RNA MALAT1 and its target microRNA-125b associate with disease risk, severity, and major adverse cardiovascular event of coronary heart disease. J. Clin. Lab. Anal. 35 (4), e23593 (2021).","journal-title":"J. Clin. Lab. Anal."},{"issue":"4","key":"1153_CR39","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.18632\/aging.101766","volume":"11","author":"Y Zhu","year":"2019","unstructured":"Zhu, Y., Yang, T., Duan, J., Mu, N. & Zhang, T. MALAT1\/miR-15b-5p\/MAPK1 mediates endothelial progenitor cells autophagy and affects coronary atherosclerotic heart disease via mTOR signaling pathway. Aging (Albany NY). 11 (4), 1089\u20131109 (2019).","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"1153_CR40","doi-asserted-by":"publisher","first-page":"e24036","DOI":"10.1002\/jcla.24036","volume":"35","author":"S Liu","year":"2021","unstructured":"Liu, S., Hou, J., Gu, X., Weng, R. & Zhong, Z. Characterization of LncRNA expression profile and identification of functional LncRNAs associated with unstable angina. J. Clin. Lab. Anal. 35 (11), e24036 (2021).","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"1153_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ncrna.2020.04.001","volume":"5","author":"L Gholami","year":"2020","unstructured":"Gholami, L. et al. The LncRNA ANRIL is down-regulated in peripheral blood of patients with periodontitis. Noncoding RNA Res. 5 (2), 60\u201366 (2020).","journal-title":"Noncoding RNA Res."},{"issue":"1","key":"1153_CR42","doi-asserted-by":"publisher","first-page":"29577","DOI":"10.1038\/s41598-024-81080-z","volume":"14","author":"X Qi","year":"2024","unstructured":"Qi, X. et al. The expression profile analysis and functional prediction of LncRNAs in peripheral blood mononuclear cells in maintenance Hemodialysis patients developing heart failure. Sci. Rep. 14 (1), 29577 (2024).","journal-title":"Sci. Rep."},{"issue":"17","key":"1153_CR43","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1111\/jcmm.17835","volume":"27","author":"T Wang","year":"2023","unstructured":"Wang, T. et al. MALAT1\/miR-185-5p mediated high glucose-induced oxidative stress, mitochondrial injury and cardiomyocyte apoptosis via the RhoA\/ROCK pathway. J. Cell. Mol. Med. 27 (17), 2495\u20132506 (2023).","journal-title":"J. Cell. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01153-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T19:03:04Z","timestamp":1746990184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-01153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1153"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-01153-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5044261\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,11]]},"assertion":[{"value":"6 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the ethics committee of the hospital and was conducted in accordance with the principles of the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"16376"}}